Skip to main content

Division of Nephrology and Hypertension Archives

Research explores barriers to kidney disease screening

Mar. 15, 2018—New research by Vanderbilt nephrologists highlights potential barriers that may prevent black Americans from being screened for kidney disease.

Read more


Major grant to enhance kidney disease research

Sep. 28, 2017—Vanderbilt’s Division of Nephrology and Hypertension has received a five-year, $5 million federal grant to provide core research services in the fight against kidney disease.

Read more


Vanderbilt, Bayer collaborate to develop new therapies against kidney diseases

Sep. 11, 2017—Vanderbilt University Medical Center (VUMC) and Bayer have agreed on a five-year strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases, with the goal of accelerating the translation of innovative approaches from the laboratory to pre-clinical development.

Read more


End-stage kidney disease study seeks to delay dialysis

Aug. 31, 2017—Vanderbilt University Medical Center (VUMC) is studying the safety of a possible treatment for diabetic kidney disease that would delay or prevent the need for kidney replacement such as dialysis.

Read more


EETs contribute to insulin sensitivity

May. 11, 2017—Interventions that increase circulating levels of compounds called EETs may improve insulin sensitivity and treat hypertension.

Read more


Building the basement membrane

Nov. 21, 2016—Vanderbilt researchers have discovered steps in the regulation of a key enzyme that builds the basement membrane, a structure that undergirds nearly all animal tissues.

Read more


VUMC mourns loss of Nephrology’s Schulman

Aug. 30, 2016—Gerald Schulman, M.D., professor of Medicine, died Aug. 26. He was 65.

Read more


Harris to lead American Society of Nephrology

Nov. 12, 2015—Ray Harris, M.D., has been elected president of the American Society of Nephrology during the society’s annual meeting, ASN Kidney Week 2015, in San Diego.

Read more


Inflammation, obesity and diabetes

Oct. 29, 2015—Vanderbilt study adds to the mounting role for inflammatory signaling in obesity.

Read more


Study shows lower systolic BP targets reduce death risk

Sep. 17, 2015—The initial results of a landmark clinical trial sponsored by the National Institutes of Health (NIH) indicate lowering systolic blood pressure below a commonly recommended target significantly reduces rates of cardiovascular events and lowers risk of death in a group of adults 50 years and older.

Read more


Upcoming Events

MORE EVENTS »